Cerity Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $42.5M | Buy |
|
|||||
|
2025
Q2 | $39.9M | Sell |
|
|||||
|
2025
Q1 | $55.7M | Buy |
|
|||||
|
2024
Q4 | $49.4M | Buy |
|
|||||
|
2024
Q3 | $46.1M | Buy |
|
|||||
|
2024
Q2 | $26.7M | Sell |
|
|||||
|
2024
Q1 | $47.3M | Buy |
|
|||||
|
2023
Q4 | $19.3M | Buy |
|
|||||
|
2023
Q3 | $18.7M | Sell |
|
|||||
|
2023
Q2 | $39.3M | Buy |
|
|||||
|
2023
Q1 | $42.1M | Buy |
|
|||||
|
2022
Q4 | $34.7M | Buy |
|
|||||
|
2022
Q3 | $20.5M | Sell |
|
|||||
|
2022
Q2 | $22.5M | Buy |
|
|||||
|
2022
Q1 | $17.4M | Buy |
|
|||||
|
2021
Q4 | $13.5M | Buy |
|
|||||
|
2021
Q3 | $11.6M | Buy |
|
|||||
|
2021
Q2 | $11.9M | Sell |
|
|||||
|
2021
Q1 | $11.3M | Sell |
|
|||||
|
2020
Q4 | $13.4M | Buy |
|
|||||
|
2020
Q3 | $10.1M | Buy |
|
|||||
|
2020
Q2 | $5.01M | Buy |
|
|||||
|
2020
Q1 | $2.81M | Sell |
|
|||||
|
2019
Q4 | $3.58M | Buy |
|
|||||
|
2019
Q3 | $2.3M | Sell |
|
|||||
|
2019
Q2 | $2.1M | Sell |
|
|||||
|
2019
Q1 | $2.42M | Sell |
|
|||||
|
2018
Q4 | $2.71M | Buy |
|
|||||
|
2018
Q3 | $3.21M | Buy |
|
|||||
|
2018
Q2 | $2.69M | Buy |
|
|||||
|
2018
Q1 | $3.04M | Sell |
|
|||||
|
2017
Q4 | $3.35M | Buy |
|
|||||
|
2017
Q3 | $3.33M | Sell |
|
|||||
|
2017
Q2 | $5.92M | Buy |
|
|||||
|
2017
Q1 | $2.4M | Buy |
|